Ametris - formerly ActiGraph

Ametris - formerly ActiGraph Ametris is pioneering the digital transformation of clinical research

06/03/2026

Artificial Intelligence is rapidly transforming clinical research, creating new opportunities to capture more objective, scalable, and meaningful patient data.

At the recent ADDS 2026 scientific conference, a focused session featuring experts and scientists from Pfizer, Mayo Clinic, U.S. Food and Drug Administration, University of California, Los Angeles, and Ametris explored how AI and machine learning are advancing digital measure development, improving sensor data quality, enabling remote patient monitoring, and shaping the future of regulatory science.

Watch the ADDS 2026 AI Session on demand using the link below ⬇️

Thank you again to our featured session presenters:
🔹Sheraz Khan, PhD at Pfizer
🔹Kimberly Kontson, PhD at U.S. FDA
🔹Jonas Paludo, MD at Mayo Clinic
🔹Michael Pettinati, PhD at Ametris
🔹Yuzhe Yang, PhD at UCLA & Google

The Ametris team had an incredible time at this weekend! 🧬 One of the highlights was sharing research presented by Dr....
06/01/2026

The Ametris team had an incredible time at this weekend! 🧬

One of the highlights was sharing research presented by Dr. Jonas Paludo from the Mayo Clinic and co-authored by Michael Pettinati, PhD demonstrating how continuous wearable monitoring enables earlier identification of Cytokine Release Syndrome (CRS) in outpatient CAR T-cell therapy.

Connect with an expert to discuss how to advance your oncology research with digital health technologies: https://hubs.la/Q04jBqfz0

06/01/2026

In our latest webinar, experts from biopharma, public health, technology, and non-profit organizations discuss how continuous remote monitoring and pre-competitive collaboration could:
✔️ Expand safe outpatient immunotherapy administration
✔️ Detect adverse events like CRS before traditional standards of care
✔️ Increase access to treatment in community care settings
✔️ Empower health care providers to treat more patients with confidence

🎥 Watch the on-demand webinar now: https://hubs.la/Q04jzg-C0

New Article Alert: Digital Health Technology for the Early Detection of CRS in Decentralized Oncology Trials We’re excit...
05/27/2026

New Article Alert: Digital Health Technology for the Early Detection of CRS in Decentralized Oncology Trials

We’re excited to share this new article in International Clinical Trials by Michael Pettinati and Samantha McClenahan about how continuous remote monitoring can derisk CRS and enable safer outpatient delivery and broader patient access to life-changing immunotherapy.

Read the full piece, and join us for a webinar tomorrow where the authors will provide additional insights into CRS detection and management and introduce DECODE CRS, a new precompetitive coalition that is tackling this industry-wide challenge head-on: https://hubs.la/Q04hYRBN0

05/20/2026

Behind the tremendous amount of work and dedication required to bring new therapies to market are real people navigating real-life challenges and experiences. Today, we thank and honor patients for International Clinical Trials Day. Their contributions make medical innovation possible.

Explore our Patient Voice Library to hear first hand patient accounts of the most impactful symptoms of their conditions and learn how DHTs can help us better understand how they feel and function in their everyday lives. Link below in the comments ⤵️

Immunotherapy treatments such as CAR-T and T-cell engagers (TcEs) are transforming patient care across oncology and immu...
05/19/2026

Immunotherapy treatments such as CAR-T and T-cell engagers (TcEs) are transforming patient care across oncology and immunology—but access remains limited by variability in monitoring, inconsistent data collection, and a lack of standardization across care settings.

Join us on next week on Wednesday, May 27th for our next Digital Health Monthly webinar: Scaling Access to Immunotherapy Treatments Through Pre-Competitive Collaboration: Introducing the DECODE CRS Coalition

During the webinar, a multidisciplinary panel of experts from Boehringer Ingelheim, the Digital Medicine Society (DiMe), National Cancer Institute, Genentech, and Ametris will explore how fit-for-purpose DHTs and precise, standardized data collection can provide a more continuous, objective view of the patient experience following immunotherapy infusion. These advances support earlier detection of change, increase confidence in care decisions, and enable more scalable treatment models through outpatient and community-based care.

We will also introduce the DECODE CRS Coalition and share why this pre-competitive, collaborative approach is critical to advancing system-wide solutions that enable safer care, broader access to life-changing immunotherapies, and improved patient outcomes in real-world settings.

Register now: https://hubs.la/Q04h7XMj0

Can’t make the live webinar? Register now and you’ll receive the on-demand recording in your inbox!

05/18/2026

The industry-wide shift toward precise digital health technologies (DHTs) allows clinical research teams to capture a more complete view of patient function and behavior over time. However, the promise of DHT cannot be realized without consistent device adherence. When patients do not wear their devices, missing data can undermine endpoint integrity and create costly risks for clinical studies.

With flexible monitoring approaches tailored to different study goals and operational needs, Ametris’ ActiTrack adherence solutions help study teams proactively identify risks, intervene when needed, and maximize data completeness.

To learn more about the most advanced DHT adherence monitoring solution in the industry, visit: https://hubs.la/Q04h22FR0 https://hubs.la/Q04h22FR0

Join the Ametris team at ACSM 2026 in Salt Lake City, Utah on May 26-29!If you'll be attending , we'd love to discuss h...
05/18/2026

Join the Ametris team at ACSM 2026 in Salt Lake City, Utah on May 26-29!

If you'll be attending , we'd love to discuss how our wearable technology solutions can help you achieve your research objectives. Reach out to Hayden Davis and Madisen Pooton directly in advance, or schedule a meeting using the link below. We hope to see you in Salt Lake City!

Schedule a meeting: https://hubs.la/Q04h22Bl0

An Exciting New Chapter for Digital Health in Clinical Research! Today, we’re proud to share that Ametris is now a Signa...
05/14/2026

An Exciting New Chapter for Digital Health in Clinical Research!

Today, we’re proud to share that Ametris is now a Signant Health company.

This strategic acquisition brings together industry-leading eCOA solutions with validated, wearable-derived digital outcome measures for the first time. By integrating patient-reported outcomes with continuous sensor data through a single, coordinated platform, Ametris and Signant are helping shape a new era of clinical research defined by deeper patient insights, stronger efficacy evidence, and more streamlined clinical trial ex*****on.

Together, we believe this powerful alliance will help transform how clinical trials are designed, conducted, and measured by simplifying fragmented technology ecosystems while enabling richer, more connected patient data.

Read the full announcement to learn more: https://hubs.la/Q04gCz0H0

In oncology research, capturing meaningful patient data without adding burden remains a major challenge that contributes...
05/12/2026

In oncology research, capturing meaningful patient data without adding burden remains a major challenge that contributes to slower adoption of DHTs compared to other therapeutic areas.

In the Phase 3 LIBERTAS trial for metastatic castration-sensitive prostate cancer (mCSPC), Johnson & Johnson Innovative Medicine achieved nearly 90% wearable adherence over 12+ months of actigraphy monitoring using a real-time, intervention workflow.

Check out our newest case study to explore how implementation of a data-driven intervention strategy can increase sustained wearable adherence, improve data completeness, and reduce variability in long-duration oncology studies involving older, clinically complex populations.

Access the case study: https://hubs.la/Q04gj5RD0

Address

Pensacola, FL

Opening Hours

Monday 8am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+18503327900

Website

Alerts

Be the first to know and let us send you an email when Ametris - formerly ActiGraph posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ametris - formerly ActiGraph:

Shortcuts

Featured

Share

Category